Favorable outcome of neoadjuvant endocrine treatment than surgery‐first in female HR‐positive/HER2‐negative breast cancer patients—A NCDB analysis (2010–2016). - Xu, Peng; Luo, Wen; Hu, Jingjing; Ma, Xiaobin; Hao, Qian; Hui, Wentao; Zhou, Zhangjian; Lin, Shuai; Wang, Meng; Wu, Hao; Dai, Zhijun; Kang, Huafeng (Cancer Medicine, 2024)